LeadMuta Biotechnology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
LeadMuta Biotechnology - overview
Established
2021
Location
Suzhou, Jiangsu, China
Primary Industry
Biotechnology
About
Based in Suzhou, China, and established in 2021, LeadMuta Biotechnology is a biotechnology company that focuses on pharmaceutical applied Artificial Intelligence (AI) technology. The company's team members are from corporations, such as MIT, Roche, and AstraZeneca, who have experience in the R&D fields of small molecule drugs, anti-tumor drugs, and anti-virus drugs. LeadMuta Biotechnology engages in the R&D of AI small molecular drugs, which enable shorter times for compound synthesis and drug screening, based on machine learning technology.
Current Investors
Zhengxuan Capital, Ruifeng Principal, Changhe Capital
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Healthcare IT
Verticals
Artificial Intelligence
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.